Invesco Ltd. Bio N Tech Se Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Invesco Ltd. holds 74,156 shares of BNTX stock, worth $7.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,156

Previous 681,100 89.11%

Holding current value

$7.64 Million

Previous $72.5 Million 89.92%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$96.22 - $115.31 $58.4 Million - $70 Million	-606,944 Reduced 89.11%	74,156 $7.31 Million
Q2 2025 Aug 13, 2025	BUY	$86.65 - $120.54 $3.12 Million - $4.33 Million	35,958 Added 5.57%	681,100 $72.5 Million
Q1 2025 May 12, 2025	BUY	$91.06 - $126.88 $50.8 Million - $70.8 Million	558,389 Added 643.65%	645,142 $58.7 Million
Q4 2024 Feb 13, 2025	SELL	$99.72 - $122.68 $100,218 - $123,293	-1,005 Reduced 1.15%	86,753 $9.89 Million
Q3 2024 Nov 12, 2024	BUY	$78.36 - $124.66 $489,514 - $778,751	6,247 Added 7.66%	87,758 $10.4 Million

Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $1.61 Million - $2.05 Million	-19,975 Reduced 19.68%	81,511 $6.55 Million
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $1.29 Million - $1.63 Million	14,524 Added 16.7%	101,486 $9.36 Million
Q4 2023 Feb 12, 2024	BUY	$90.91 - $112.75 $238,820 - $296,194	2,627 Added 3.11%	86,962 $9.18 Million
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $571,300 - $725,464	5,800 Added 7.39%	84,335 $9.16 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $551,367 - $696,922	5,375 Added 7.35%	78,535 $8.48 Million
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $665,677 - $834,581	5,431 Added 8.02%	73,160 $9.11 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $722,659 - $1.14 Million	-6,102 Reduced 8.26%	67,729 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $512,897 - $735,735	4,018 Added 5.76%	73,831 $9.96 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $160,101 - $241,925	-1,299 Reduced 1.83%	69,813 $10.4 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $239,875 - $440,515	1,900 Added 2.75%	71,112 $12.1 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $13.4 Million - $22.4 Million	61,694 Added 820.62%	69,212 $17.8 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $272,445 - $591,685	1,323 Added 21.36%	7,518 $2.05 Million
Q2 2021 Aug 17, 2021	BUY	$113.32 - $241.49 $702,017 - $1.5 Million	6,195 New	6,195 $1.39 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $1.75 Million - $2.45 Million	-20,468 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $41.8 Million - $74.4 Million	-574,404 Reduced 96.56%	20,468 $1.67 Million
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $28.7 Million - $51.7 Million	496,759 Added 506.31%	594,872 $41.2 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $3.79 Million - $6.55 Million	98,113 New	98,113 $6.55 Million

Others Institutions Holding BNTX

# of Institutions

318

Shares Held

43.6M

Call Options Held

1.15M

Put Options Held

1.36M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account